Stocksigma LogoStocksigma Logo

Indegene Receives Frost & Sullivan 2026 Global AI Pharma Leadership Recognition

Indegene has received Frost & Sullivan鈥檚 2026 Global Enabling Technology Leadership Recognition for AI-powered pharma commercialization services on 22nd

Indegene Receives Frost & Sullivan 2026 Global AI Pharma Leadership Recognition

Indegene Ltd 路 Press Release 路 22 Oct 2026, 4:07 pm

Indegene Receives Frost & Sullivan 2026 Global AI Pharma Leadership Recognition Indegene has received Frost & Sullivan鈥檚 2026 Global Enabling Technology Leadership Recognition for AI-powered pharma commercialization services on 22nd Oct'26. The recognition highlights Indegene's strategy effectiveness, execution scale, and proprietary solutions like its Pharma Operating System and Cortex reasoning engine across commercial, medical, regulatory, and analytics workflows. Currently trusted by the world's top 20 biopharma companies, the recognition validates Indegene鈥檚 competitive positioning, enterprise generative AI capabilities, and domain-led operating model within the global life sciences technology and commercialization landscape.

Original exchange filing (PDF)

More announcements from Indegene Ltd

All Indegene Ltd announcements